Holger Nückel

2.5k total citations
59 papers, 1.9k citations indexed

About

Holger Nückel is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Holger Nückel has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 22 papers in Immunology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Holger Nückel's work include Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (18 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Holger Nückel is often cited by papers focused on Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (18 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Holger Nückel collaborates with scholars based in Germany, Italy and United States. Holger Nückel's co-authors include Ulrich Dührsen, Jan Dürig, Winfried Siffert, Ludger Sellmann, Vera Rebmann, Ludger Klein‐Hitpaß, Ulrich H. Frey, Anja Führer, Hans Grosse‐Wilde and Tarik Möröy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Holger Nückel

59 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger Nückel Germany 27 810 749 625 535 426 59 1.9k
Florence Ajchenbaum‐Cymbalista France 23 909 1.1× 612 0.8× 670 1.1× 550 1.0× 575 1.3× 40 1.7k
Roberta Pacini Italy 15 520 0.6× 535 0.7× 882 1.4× 601 1.1× 567 1.3× 20 1.9k
Katja Zirlik Germany 25 894 1.1× 814 1.1× 707 1.1× 1.1k 2.0× 581 1.4× 45 2.4k
Maria Teresa Sabrina Bertilaccio Italy 25 632 0.8× 837 1.1× 339 0.5× 550 1.0× 430 1.0× 51 1.7k
Oliver Manzke Germany 19 405 0.5× 676 0.9× 549 0.9× 552 1.0× 627 1.5× 36 1.9k
Mats Merup Sweden 24 1.1k 1.4× 658 0.9× 969 1.6× 739 1.4× 632 1.5× 59 2.2k
Abel Sánchez‐Aguilera Spain 21 564 0.7× 485 0.6× 508 0.8× 1.0k 1.9× 646 1.5× 31 2.2k
Ivana Pierri Italy 22 447 0.6× 762 1.0× 670 1.1× 268 0.5× 601 1.4× 72 2.0k
Inga Vater Germany 21 315 0.4× 324 0.4× 701 1.1× 594 1.1× 377 0.9× 35 1.6k
Outi Kuittinen Finland 23 526 0.6× 393 0.5× 1.3k 2.0× 309 0.6× 848 2.0× 104 2.0k

Countries citing papers authored by Holger Nückel

Since Specialization
Citations

This map shows the geographic impact of Holger Nückel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Nückel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Nückel more than expected).

Fields of papers citing papers by Holger Nückel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Nückel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Nückel. The network helps show where Holger Nückel may publish in the future.

Co-authorship network of co-authors of Holger Nückel

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Nückel. A scholar is included among the top collaborators of Holger Nückel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Nückel. Holger Nückel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nolte, Florian, Holger Nückel, Burkhard Schmidt, et al.. (2018). Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study. Journal of Cancer Research and Clinical Oncology. 144(8). 1531–1538. 2 indexed citations
2.
Nückel, Holger, et al.. (2012). Simple Methods for the Detection of HLA-G Variants in Coding and Non-coding Regions. Methods in molecular biology. 882. 123–142. 4 indexed citations
3.
Sellmann, Ludger, Dirk de Beer, Marius Bartels, et al.. (2011). Telomeres and prognosis in patients with chronic lymphocytic leukaemia. International Journal of Hematology. 93(1). 74–82. 24 indexed citations
4.
Aydin, Semra, Florian Grabellus, Lewin Eisele, et al.. (2011). Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. European Journal Of Haematology. 87(1). 10–19. 21 indexed citations
5.
Bachmann, Hagen S., Lukas C. Heukamp, Klaus J. Schmitz, et al.. (2011). Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma. International Journal of Cancer. 129(10). 2390–2399. 37 indexed citations
6.
Johansson, Patricia, Lewin Eisele, Ludger Klein‐Hitpaß, et al.. (2010). Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leukemia Research. 34(7). 892–898. 26 indexed citations
7.
Nückel, Holger, M Switała, Ludger Sellmann, et al.. (2010). The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia. 24(6). 1152–1159. 97 indexed citations
8.
Meyer, Christophe, N. Ansorge, Ines Siglienti, et al.. (2010). Mitoxantron-assoziierte akute Leukämie bei Multipler Sklerose. Der Nervenarzt. 81(12). 1483–1489. 1 indexed citations
9.
Wedemeyer, Christian, et al.. (2009). BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty. European journal of medical research. 14(6). 250–250. 13 indexed citations
10.
Zenz, Thorsten, Axel Benner, Ulrich Dührsen, et al.. (2009). BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia. Leukemia & lymphoma. 50(11). 1837–1842. 11 indexed citations
11.
Nückel, Holger, et al.. (2009). High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Clinical Immunology. 131(3). 472–480. 25 indexed citations
12.
Nückel, Holger, Ulrich H. Frey, Ludger Sellmann, et al.. (2009). FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. European Journal Of Haematology. 83(6). 541–549. 11 indexed citations
13.
Ortmann, Christina A., Lewin Eisele, Holger Nückel, et al.. (2008). Aberrant hypomethylation of the cancer–testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia. Annals of Hematology. 87(10). 809–818. 52 indexed citations
14.
Rebmann, Vera, Holger Nückel, Ulrich Dührsen, & Hans Grosse‐Wilde. (2007). HLA-G in B-chronic lymphocytic leukaemia: Clinical relevance and functional implications. Seminars in Cancer Biology. 17(6). 430–435. 27 indexed citations
15.
Sellmann, Ludger, Stefan Gesk, Matthias Ritgen, et al.. (2007). Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B‐chronic lymphocytic leukaemia. British Journal of Haematology. 138(2). 217–220. 27 indexed citations
16.
Nückel, Holger, Andreas Hüttmann, Ludger Klein‐Hitpaß, et al.. (2006). Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leukemia & lymphoma. 47(6). 1053–1061. 43 indexed citations
17.
Nückel, Holger, et al.. (2006). Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry. Clinical & Laboratory Haematology. 28(1). 22–29. 34 indexed citations
18.
Kasper, Christoph, et al.. (2005). Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study. Annals of Hematology. 84(12). 796–801. 13 indexed citations
19.
Nückel, Holger, Ulrich H. Frey, Jan Dürig, Ulrich Dührsen, & Winfried Siffert. (2004). 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. European Journal Of Haematology. 72(4). 259–263. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florence Ajchenbaum‐Cymbalista Breakdown of academic impact, for papers by Roberta Pacini Breakdown of academic impact, for papers by Katja Zirlik Breakdown of academic impact, for papers by Maria Teresa Sabrina Bertilaccio Breakdown of academic impact, for papers by Oliver Manzke Breakdown of academic impact, for papers by Mats Merup Breakdown of academic impact, for papers by Abel Sánchez‐Aguilera Breakdown of academic impact, for papers by Ivana Pierri Breakdown of academic impact, for papers by Inga Vater Breakdown of academic impact, for papers by Outi Kuittinen
Rankless by CCL
2026